vimarsana.com
Home
Live Updates
New Late-breaking Data Reinforce the Benefits of Abbott's Tr
New Late-breaking Data Reinforce the Benefits of Abbott's Tr
New Late-breaking Data Reinforce the Benefits of Abbott's TriClip Device for People with Tricuspid Valve Disease
Data presented at EuroPCR 2023 build on prior study results demonstrating TriClip is a safe and effective therapy to treat leaky tricuspid valves
Related Keywords
Paris ,
France General ,
France ,
Canada ,
Leipzig ,
Sachsen ,
Germany ,
Andreas Brieke ,
Philipp Lurz ,
William Abraham ,
Abbott Triclip ,
Rebecca Hahn ,
Michael Dale ,
Federico Asch ,
European Association Of The Percutaneous Cardiovascular Interventions ,
York Heart Association ,
Heart Center Leipzig At University ,
European Association ,
Percutaneous Cardiovascular Interventions ,
Day Outcomes From ,
New York Heart Association ,
Functional Class ,
Kansas City Cardiomyopathy Questionnaire ,
Heart Center Leipzig ,
Transcatheter Tricuspid Valve Repair Content ,
Tricuspid Valve Imaging ,
Interventions Developing Hand In ,
Tricuspid Device Clinical Trial Overview ,
Ori Ben Yehuda ,
Portico Content ,
Treat Heart Failure ,
Echocardiographic Findings ,